Translational Research in Pediatric and Obstetric Pharmacology (R21)

The summary for the Translational Research in Pediatric and Obstetric Pharmacology (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Translational Research in Pediatric and Obstetric Pharmacology (R21): Purpose. This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development encourages research grant applications to conduct studies to improve existing drug saftey and efficacy, and to develop new drugs for pediatric and obstetric populations. The overall goals of this FOA are to support: (1) pharmacological studies addressing the special differences of drug actions and responses among children at various developmental stages, between children and adults, and between pregnant and non-pregnant women; (2) development of new drug targeting children and pregnant women; (3) multidisciplinary collaborations between basic and physician scientists to improve the use of therapeutics in obstetrics and pediatrics. Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with FOAs of identical scientific scope, PAR-09-155, that encourages applications under the R01 grant mechanism and PAR-09-154 that encourages applications under the R03 grant mechanism. Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received.

Federal Grant Title:	Translational Research in Pediatric and Obstetric Pharmacology (R21)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health Income Security and Social Services
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-09-156
Type of Funding:	Grant
CFDA Numbers:	93.865
CFDA Descriptions:	Child Health and Human Development Extramural Research
Current Application Deadline:	May 19, 2011
Original Application Deadline:	May 19, 2011
Posted Date:	Apr 10, 2009
Creation Date:	Apr 10, 2009
Archive Date:	Jun 19, 2011
Total Program Funding:
Maximum Federal Grant Award:	$275,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • The Road to Prevention of Stillbirth Data Coordinating Center (UM2 Clinical Trial Not All...; • The Road to Prevention of Stillbirth Clinical Research Centers (UG1 Clinical Trial Option...; • Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial...; • Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allo...; • National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 C...; • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...; • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...; • Reproductive Genetics and Epigenetics
More Grants from the National Institutes of Health: • Urology Centers Program Interactions Core (U24 Clinical Trial Not Allowed); • Coordinating Center to Support Consortium for Neuroscience Alzheimers Disease (AD) and AD-...; • Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials o...; • Administrative Supplements to Promote Diversity in Research and Development Small Business...; • Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R21 Clinical Trial...